Biodexa Pharmaceuticals Plc
BDRX
$7.45
-$0.06-0.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.06% | -54.61% | 1.59% | 24.51% | 0.52% |
| Total Depreciation and Amortization | 6.01% | 18.71% | -1.59% | -12.00% | -0.46% |
| Total Amortization of Deferred Charges | -- | -- | 0.00% | -- | -- |
| Total Other Non-Cash Items | 6.08% | 117.41% | 1.59% | -209.18% | 0.52% |
| Change in Net Operating Assets | -5.90% | 98.52% | 1.59% | -238.82% | 0.52% |
| Cash from Operations | -6.07% | 56.41% | 1.59% | -59.96% | 0.52% |
| Capital Expenditure | 0.00% | 77.59% | 1.69% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.08% | -300.76% | -1.58% | 122.58% | 0.52% |
| Cash from Investing | -6.04% | -313.71% | -1.58% | 121.34% | 0.52% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | -148.39% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 0.00% | 44.46% | 0.00% | -8.67% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 98.67% | 0.00% | -- | -- |
| Cash from Financing | 6.06% | 51.09% | -1.59% | -13.12% | -0.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.06% | 168.75% | 1.58% | -281.29% | 0.52% |